1227187-59-8 Usage
Description
Cyclohexanecarboxylic acid, 4-(1-Methylethoxy)-, ethyl ester, transis a colorless liquid chemical compound with the molecular formula C12H22O2. It is commonly used as a flavoring agent in the food industry and in the production of fragrances and perfumes.
Uses
Used in Food Industry:
Cyclohexanecarboxylic acid, 4-(1-Methylethoxy)-, ethyl ester, transis used as a flavoring agent to enhance the taste and aroma of various food products.
Used in Fragrance and Perfume Industry:
Cyclohexanecarboxylic acid, 4-(1-Methylethoxy)-, ethyl ester, transis used in the production of fragrances and perfumes to provide a pleasant and distinctive scent.
Safety Precautions:
It is important to handle Cyclohexanecarboxylic acid, 4-(1-Methylethoxy)-, ethyl ester, transwith care as it can be harmful if inhaled, ingested, or comes into contact with the skin. Additionally, it should be stored in a cool, dry place away from heat and ignition sources to prevent any potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 1227187-59-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,7,1,8 and 7 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1227187-59:
(9*1)+(8*2)+(7*2)+(6*7)+(5*1)+(4*8)+(3*7)+(2*5)+(1*9)=158
158 % 10 = 8
So 1227187-59-8 is a valid CAS Registry Number.
1227187-59-8Relevant articles and documents
OXY-CYCLOHEXYL-4H,6H-5-OXA-2,3,10B-TRIAZA-BENZO[E]AZULENES AS V1A ANTAGONISTS
-
Page/Page column 24; 25, (2013/04/13)
The present invention provides 4H,6H-5-oxa-2,3,10b-triaza-benzo[e]azulenes, which act as V1a receptor modulators, and in particular as Via receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful as therapeutics acting peripherally and centrally in the conditions of dysmenorrhea, male or female sexual dysfunction, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, anxiety, depressive disorders, obsessive compulsive disorder, autistic spectrum disorders, schizophrenia, and aggressive behavior.
